Thalidomide (50mg)

DRUG4 trials

Sponsors

Shanghai Jiao Tong University School of Medicine, Shanghai Zhongshan Hospital, Wenjie Zheng, Second Affiliated Hospital, Zhejiang University, School of Medicine

Conditions

BevacizimabGastrointestinal Vascular MalformationHHTHepatocellular Cancer (HCC)Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome

Phase 2

Bevacizumab in the Treatment of HHT

RecruitingNCT07828015

Second Affiliated Hospital, Zhejiang University, School of MedicineBevacizimab, HHT

Start: 2025-05-01End: 2029-09-01Target: 40Updated: 2026-09-18

Phase 3

the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation

CompletedNCT02707484

Shanghai Jiao Tong University School of MedicineGastrointestinal Vascular Malformation

Start: 2016-04-30End: 2021-04-30Updated: 2023-06-23

Unknown Phase

Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

CompletedNCT07321613

Shanghai Zhongshan HospitalHepatocellular Cancer (HCC)

Start: 2023-05-01End: 2025-06-01Updated: 2026-01-07

Efficacy and Safety of Thalidomide for Pediatric PFAPA Syndrome

Not yet recruitingNCT07476625

Wenjie ZhengPeriodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome

Start: 2026-04-01End: 2028-03-30Target: 106Updated: 2026-03-17

Related Papers

Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia

New England Journal of Medicine2023-11-0151 citations